Baylor Scott & White Health Again the Most-Awarded Health System in Texas for Clinical Care and Patient Experience

Baylor Scott & White Health once again leads the state of Texas in the number of accolades earned in U.S. News & World Report’s 2023-24 Best Hospitals, released today. A total of 26 Baylor Scott & White hospitals were recognized, including four facilities with a nationally ranked specialty – more than any other health system in Texas.

Baylor Scott & White Health Again the Most-Awarded Not-for-Profit Health System in Texas for Clinical Care and Patient Experience

Baylor Scott & White Health once again leads the state of Texas in the number of accolades earned in U.S. News & World Report’s 2023-24 Best Hospitals, released today. A total of 26 Baylor Scott & White hospitals were recognized, including four facilities with a nationally ranked specialty – more than any other health system in Texas.

Cedars-Sinai Ranked #2 Hospital in Nation by U.S. News & World Report

Cedars-Sinai has been named the #2 hospital in the nation and #1 in California in U.S. News & World Report’s “Best Hospitals 2022-23” rankings.

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes

Fewer than one in five adolescents and young adults with type 1 diabetes are successful in achieving the recommended 2019 A1C goal of below 7.5%, and the overwhelming majority fail to achieve the 2020 target of less than 7%. But young people who use continuous glucose monitoring (CGM) devices can significantly improve their overall blood glucose control, without increasing severe low or high glucose levels, according to findings from a 6-month, multi-center clinical trial. And both severe hypoglycemia (low glucose) and hyperglycemia (high glucose) can lead to emergency care and hospitalization.

Heart attack, stroke risk declines among people with diabetes

The rate of heart attacks, strokes and other cardiovascular complications has improved among people with diabetes over the past 20 years, narrowing the gap in cardiovascular mortality rates between individuals with and without diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Coconut oil reduces features of metabolic syndrome in obese females, animal study finds

Obese females that ate a small amount of coconut oil daily, even as part of a high-fat diet, had decreased features of metabolic syndrome, a cluster of risk factors that raise the chances of developing diabetes, heart disease and stroke, an animal study finds. The study results were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society.

Wearable delivery device allows patients with type 2 diabetes to safely use more affordable insulin option

Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds. Results of the randomized controlled study—which was accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society—suggest “a more affordable option” for insulin therapy than newer insulin types, the researchers said.

Two types of diabetes drugs similarly effective in reducing heart and kidney disease

Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

Technology use by adults with type 1 diabetes lower among African Americans, Hispanics

Continuous glucose monitor (CGM) and continuous subcutaneous insulin infusion (CSII) devices are known to improve outcomes in patients with type 1 diabetes (T1D), yet African American and Hispanic patients face barriers to the use of these devices, according to results of a small single-center retrospective study. The results of the ENDO 2020 abstract will be published in the Journal of the Endocrine Society.

Loss of gland in eyelids may be a biomarker for elevated blood glucose in diabetes

In patients with diabetes, loss of the gland that helps lubricate the eye may be a sign of elevated blood glucose levels, according to research accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting. The study will be published in the Journal of the Endocrine Society.

Medtronic MiniMed 670G insulin pump allows “excellent” blood glucose control

Patients with type 1 diabetes who use Medtronic’s MiniMedTM 670G insulin pump system are able to maintain blood glucose levels in the targeted range over 71% of the time, according to a study that analyzed some 6 million days of real-world data. Results of the industry-supported study were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental issue of the Journal of the Endocrine Society.

Bariatric surgery before diabetes develops leads to greater weight loss

Obese patients may lose more weight if they undergo bariatric surgery before they develop diabetes, suggests a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting. The research will be published in a special supplemental issue of the Journal of the Endocrine Society.

Better controlled diabetes is associated with preserved cognitive function following stroke

Better glucose control can help people with diabetes who have a common type of stroke to preserve their cognitive function, according to a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting. The abstract will be published in a special supplemental issue of the Journal of the Endocrine Society.

Diabetes care reaches new heights as drone delivers insulin for patient

The international medical team that accomplished the world’s first documented drone delivery of insulin for a patient living in a remote community described the project in an ENDO 2020 abstract that will be published in the Journal of the Endocrine Society.

Virtual ENDO 2020 news conferences to highlight advances in technology, thyroid health

Researchers will discuss how artificial intelligence and drones are being incorporated into health care when they share the latest emerging science during the Endocrine Society’s ENDO 2020 virtual news conferences March 30-31.

First-ever quality measures aim to reduce diabetes complications

The Endocrine Society and Avalere Health introduced the first-ever quality measures to help healthcare providers assess how well they identify and care for older adults at greater risk of hypoglycemia—low blood sugar that can be a dangerous complication of diabetes treatment.

People with type 1 diabetes still struggle with blood sugar control despite continuous glucose monitoring (CGM)

Some continuous glucose monitoring (CGM) alarm features and settings may achieve better blood sugar control for people with type 1 diabetes, according to a study published in the Journal of the Endocrine Society.

Mount Sinai Ranked Among the Top in the Nation by U.S. News & World Report

The Hospital was ranked No. 14 nationally, up four spots from last year. Eight departments within the Hospital were ranked among the top 20 nationally in their specialties, up from five last year